Skip to main content
. 2014 Jul 8;14:54. doi: 10.1186/1472-6823-14-54

Table 5.

Overall survival

  Number Mean survival times (years) 95% CI χ 2 P- value
All
168
8.94 ± 0.28
8.40-9.48
 
 
Age
 
 
 
4.33
0.04*
  ≤ 50
76
9.50 ± 0.29
8.92-10.07
 
 
  > 50
92
7.46 ± 0.38
6.73-8.20
 
 
Gender
 
 
 
4.25
0.04*
  Male
102
9.31 ± 0.27
8.78-9.84
 
 
  Female
66
7.71 ± 0.61
6.52-8.91
 
 
Site
 
 
 
4.40
0.11
Rectum
99
9.40 ± 0.27
8.88-9.92
 
 
Pancreas
23
4.09 ± 0.48
3.14-5.03
 
 
Othersa
46
7.59 ± 0.57
6.47-8.72
 
 
Size
 
 
 
18.485
<0.01*
< 1 cm
44
9.84 ± 0.16
9.53-10.15
 
<0.01c
1-2 cm
50
8.88 ± 0.28
8.34-9.42
 
0.01c
> 2 cm
51
5.06 ± 0.51
4.07-6.06
 
 
Unclearb
23
8.50 ± 0.39
7.74-9.26
 
0.01c
Tumor type
 
 
 
58.840
<0.01*
NET
41
7.35 ± 0.63
6.13-8.58
 
<0.01c
NEC
12
2.80 ± 0.87
1.09-4.50
 
 
Unclear 115 9.80 ± 0.14 9.53-10.08    

aothers represent stomach, duodenum, jejunum, ileum, colon, appendix.

bspecimens too small to be properly described tumor size.

clog-rank test (pairwise over strata) according to size and tumor type; the P-values of tumor size 1 cm vs. > 2 cm, 1–2 cm vs. > 2 cm, Unclear vs. > 2 cm and NET vs. NEC were < 0.05.

*P <0.05.

NET, neuroendocrine tumor; NEC, neuroendocrine carcinoma.